Complications associated with perioperative use of tyrosine kinase inhibitor in cytoreductive nephrectomy

Recent clinical trials have investigated the benefit of combining tyrosine kinase inhibitors (TKIs) and cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma. Our goal is to determine whether the perioperative use of TKIs increases the postoperative morbidity following CN i...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Filipe L. F., Zheng, Chaoyi, Witmer, Kenneth, O’neill, John, Lynch, John H., Kowalczyk, Keith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813342/
https://www.ncbi.nlm.nih.gov/pubmed/31649310
http://dx.doi.org/10.1038/s41598-019-51548-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813342/
https://www.ncbi.nlm.nih.gov/pubmed/31649310
http://dx.doi.org/10.1038/s41598-019-51548-4

Ejemplares similares